Joseph E. Aslan

Joseph E. Aslan

Auto-generated profile, based on publicly available information

Joseph E. Aslan

Oregon Health & Science University

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2005 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
TSThomas Simmen
Thomas Simmen
JAJoseph E Aslan
Joseph E Aslan
ABAnastassia D Blagoveshchenskaya
Anastassia D Blagoveshchenskaya
LTLaurel Thomas
Laurel Thomas
LWLei Wan
Lei Wan
GTGary Thomas
Gary Thomas
The endoplasmic reticulum (ER) and mitochondria form contacts that support communication between these two organelles, including synthesis and transfer of lipids, and the exchange of calcium, which regulates ER chaperones, mitochondrial ATP production, and apoptosis. Despite the fundamental roles for ER–mitochondria contacts, little is known about the molecules that regulate them. Here we report the identification of a multifunctional sorting protein, PACS‐2, that integrates ER–mitochondria communication, ER homeostasis, and apoptosis. PACS‐2 controls the apposition of mitochondria with the ER, as depletion of PACS‐2 causes BAP31‐dependent mitochondria fragmentation and uncoupling from the ER. PACS‐2 also controls formation of ER lipid‐synthesizing centers found on mitochondria‐associated membranes and ER homeostasis. However, in response to apoptotic inducers, PACS‐2 translocates Bid to mitochondria, which initiates a sequence of events including the formation of mitochondrial truncated Bid, the release of cytochrome c , and the activation of caspase‐3, thereby causing cell death. Together, our results identify PACS‐2 as a novel sorting protein that links the ER–mitochondria axis to ER homeostasis and the control of cell fate, and provide new insights into Bid action.

3 November 2012 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
JAJ. E. Aslan
J. E. Aslan
OMO. J. T. Mccarty
O. J. T. Mccarty

26 April 2013 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TNThe Physical Sciences - Oncology Centers Network
The Physical Sciences - Oncology Centers Network
DADavid B. Agus
David B. Agus
JAJenolyn F. Alexander
Jenolyn F. Alexander
WAWadih Arap
Wadih Arap
Shashaanka AshiliShashaanka Ashili
Shashaanka Ashili
PWPei-Hsun Wu
Pei-Hsun Wu
To investigate the transition from non-cancerous to metastatic from a physical sciences perspective, the Physical Sciences–Oncology Centers (PS-OC) Network performed molecular and biophysical comparative studies of the non-tumorigenic MCF-10A and metastatic MDA-MB-231 breast epithelial cell lines, commonly used as models of cancer metastasis. Experiments were performed in 20 laboratories from 12 PS-OCs. Each laboratory was supplied with identical aliquots and common reagents and culture protocols. Analyses of these measurements revealed dramatic differences in their mechanics, migration, adhesion, oxygen response, and proteomic profiles. Model-based multi-omics approaches identified key differences between these cells' regulatory networks involved in morphology and survival. These results provide a multifaceted description of cellular parameters of two widely used cell lines and demonstrate the value of the PS-OC Network approach for integration of diverse experimental observations to elucidate the phenotypes associated with cancer metastasis.

15 September 2011 in Blood
Verified
Journal Article
Closed access
PDF file
JAJoseph E. Aslan
Joseph E. Aslan
GTGarth W. Tormoen
Garth W. Tormoen
CLCassandra P. Loren
Cassandra P. Loren
JPJiaqing Pang
Jiaqing Pang
OMOwen J. T. McCarty
Owen J. T. McCarty
Platelet activation and thrombus formation are under the control of signaling systems that integrate cellular homeostasis with cytoskeletal dynamics. Here, we identify a role for the ribosome protein S6 kinase (S6K1) and its upstream regulator mTOR in the control of platelet activation and aggregate formation under shear flow. Platelet engagement of fibrinogen initiated a signaling cascade that triggered the activation of S6K1 and Rac1. Fibrinogen-induced S6K1 activation was abolished by inhibitors of Src kinases, but not Rac1 inhibitors, demonstrating that S6K1 acts upstream of Rac1. S6K1 and Rac1 interacted in a protein complex with the Rac1 GEF TIAM1 and colocalized with actin at the platelet lamellipodial edge, suggesting that S6K1 and Rac1 work together to drive platelet spreading. Pharmacologic inhibitors of mTOR and S6K1 blocked Rac1 activation and prevented platelet spreading on fibrinogen, but had no effect on Src or FAK kinase activation. mTOR inhibitors dramatically reduced collagen-induced platelet aggregation and promoted the destabilization of platelet aggregates formed under shear flow conditions. Together, these results reveal novel roles for S6K1 and mTOR in the regulation of Rac1 activity and provide insights into the relationship between the pharmacology of the mTOR system and the molecular mechanisms of platelet activation.

1 January 2015 in Thrombosis Research
Verified
Journal Article
Closed access
CLCassandra P. Loren
Cassandra P. Loren
JAJoseph E. Aslan
Joseph E. Aslan
RRRachel A. Rigg
Rachel A. Rigg
MNMarie S. Nowak
Marie S. Nowak
LHLaura D. Healy
Laura D. Healy
OMOwen J.T. McCarty
Owen J.T. McCarty

17 November 2011
Verified
Book Chapter
Closed access
PDF file
JAJoseph E. Aslan
Joseph E. Aslan
AIAsako Itakura
Asako Itakura
JGJacqueline M. Gertz
Jacqueline M. Gertz
OMOwen J. T. McCarty
Owen J. T. McCarty